Moreover, UBQLN2 mutants harboring ALS-FTD-linked mutations were substantially less effective than wild-type UBQLN2 in promoting TBK1 phosphorylation (Figure 3). The gene discussed is UBQLN2; the disease is frontotemporal dementia.